Challenges to the Diagnosis and Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)- Presented by Novartis Pharmaceuticals Corporation

Session Type: Innovation Theater
Tuesday, November 8, 2011: 12:30 PM-1:15 PM
Hall F1 (Booth #789) (McCormick Place West)

Session Overview:
Cryopyrin-Associated Periodic Syndrome (CAPS) is a spectrum of rare genetic diseases, which includes Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS), two lifelong autoinflammatory syndromes. CAPS symptoms are associated with increased production of IL-1β. This presentation will focus on the recognition and differential diagnosis of patients with FCAS and MWS, the role of IL-1β in the pathogenesis of CAPS, the treatment of FCAS and MWS, and case studies of patients living with CAPS. The purpose of this presentation is to increase the awareness and recognition of CAPS and provide education on the differential diagnosis of CAPS to support the appropriate diagnosis and care of patients living with CAPS.

Upon completion of this session, participants should be able to:

  • examine the signs, symptoms, and differential diagnosis of CAPS and the treatment of FCAS and MWS
  • review the role of IL-1β in the pathogenesis of CAPS
  • discuss the common signs and symptoms indicative of CAPS and how to appropriately diagnose FCAS and MWS
  • provide an overview of the treatment of FCAS and MWS
  • present clinically relevant case studies of patients living with CAPS

See more of: Innovation Theater

To see other sessions for this day, use the date buttons to the left.